EGFR and lung adenocarcinoma: Our NGS-based multi-gene mutation profiling of lung adenocarcinomas carrying the activating EGFR mutation L858R has uncovered an MLH1 V384D allele that is over-represented in a subset of tumors showing primary resistance to EGFR-TKIs.